Utah Medical Products, Inc.
UTMD
Market Cap$241.29M
Close$
$119.60
75.5% upside
Current Fair Value
75.5% upsideUndervalued by 75.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $241.29 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.1763 (1.75%) |
| Earnings per Share | $0.0 |
| Beta | 0.78 |
| Outstanding Shares | 3,589,014 |
| Avg 30 Day Volume | 33,356 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...